Skip to content
TrialScanner

NCT03808558

Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas

Phase 2Active, not recruitingSGMTCollaborator

Registry record

Lead sponsor
David E Gerber
Conditions
KRAS Gene Mutation
Primary completion
Apr 3, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03808558 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03808558: Phase 2 Study of TVB-2640 in... | TrialScanner